A groundbreaking gene therapy has allowed kids like Miles, born with otoferlin deafness, to hear normally—without cochlear implants. “A lot of people are working on how to reprogram cells of the inner ear to rebuild themselves,” UCSF's Dr. Dylan Chan tells @nytimes.com https://ucsfh.org/3QNwLU6
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
